FDA Adverse Event Injury Summary report: N

LOFRIC DILACATH

MDR report key: 3181413 · Received June 14, 2013

Report

Report Number
3009632672-2013-00022
Event Type
Injury
Date Received
June 14, 2013
Report Date
September 8, 2011
Manufacturer
WELLSPECT HEALTHCARE
Product Code
FBX
PMA / PMN Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THIS SUBMISSION IS BEING MADE AFTER AN ACQUISITION AND INTERNAL AUDIT OF WELLSPECT HEALTHCARE. SAMPLES RETURNED HAVE BEEN ANALYZED AND NO DEFECTS OR DEVIATIONS COULD BE FOUND. BASED UPON THE PRODUCT TESTING, THIS COMPLAINT COULD NOT BE CONFIRMED AS REPORTED.

Description of Event or Problem · 1

THE CUSTOMER THINKS THE COATING IS ROUGH AND HE HAD A BLEEDING AFTER CATHETERIZATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
270784 LOFRIC DILACATH URETHRAL DILATOR, FBX FBX WELLSPECT HEALTHCARE 40618 86793

Patients

Seq Age Sex Outcome Treatment
1 Other